Total Payments
$1,513
2024 Payments
$145.80
Companies
14
Transactions
77
Medicare Patients
3,121
Medicare Billing
$100,114
Payment Breakdown by Category
Food & Beverage$1,513 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,513 | 77 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $825.24 | 41 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $155.28 | 9 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $95.85 | 5 | $0 (2024) |
| AngioDynamics, Inc. | $86.96 | 1 | $0 (2018) |
| Mylan Specialty L.P. | $73.83 | 4 | $0 (2022) |
| Xeris Pharmaceuticals, Inc. | $66.86 | 4 | $0 (2021) |
| Novo Nordisk Inc | $59.07 | 4 | $0 (2021) |
| Lilly USA, LLC | $35.11 | 2 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $27.88 | 2 | $0 (2023) |
| Horizon Therapeutics plc | $19.50 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $145.80 | 8 | AstraZeneca Pharmaceuticals LP ($57.64) |
| 2023 | $224.58 | 7 | Boehringer Ingelheim Pharmaceuticals, Inc. ($191.08) |
| 2022 | $283.86 | 15 | Boehringer Ingelheim Pharmaceuticals, Inc. ($245.69) |
| 2021 | $487.27 | 29 | Boehringer Ingelheim Pharmaceuticals, Inc. ($196.37) |
| 2020 | $231.00 | 13 | Merck Sharp & Dohme Corporation ($88.16) |
| 2018 | $140.38 | 5 | AngioDynamics, Inc. ($86.96) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: DIABETES | ||||||
| 06/24/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Respiratory | ||||||
| 05/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Respiratory | ||||||
| 03/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: DIABETES | ||||||
| 02/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: DIABETES | ||||||
| 11/15/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Gastroenterology | ||||||
| 10/11/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Respiratory | ||||||
| 09/28/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $116.71 | General |
| Category: RESPIRATORY | ||||||
| 08/30/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: DIABETES | ||||||
| 06/05/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: DIABETES | ||||||
| 03/07/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: DIABETES | ||||||
| 02/07/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: DIABETES | ||||||
| 11/09/2022 | AstraZeneca Pharmaceuticals LP | EVUSHELD (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Vaccines & Immune Therapies | ||||||
| 10/05/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: DIABETES | ||||||
| 08/30/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: RESPIRATORY | ||||||
| 07/19/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: DIABETES | ||||||
| 07/13/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: RESPIRATORY | ||||||
| 06/01/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 559 | 908 | $39,384 | $20,191 |
| 2022 | 11 | 731 | 1,145 | $50,171 | $28,809 |
| 2021 | 14 | 1,292 | 1,682 | $67,027 | $40,872 |
| 2020 | 12 | 539 | 879 | $30,909 | $10,242 |
Total Patients
3,121
Total Services
4,614
Medicare Billing
$100,114
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2023 | 79 | 144 | $8,640 | $7,240 | 83.8% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 79 | 144 | $8,640 | $5,839 | 67.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 86 | 87 | $2,524 | $2,419 | 95.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 90 | 212 | $8,465 | $2,130 | 25.2% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 88 | 89 | $3,560 | $1,819 | 51.1% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 13 | 13 | $650.00 | $544.31 | 83.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 42 | 103 | $2,605 | $103.58 | 4.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 56 | 87 | $3,480 | $63.17 | 1.8% |
| 94760 | Test to measure oxygen level in blood using ear or finger device | Office | 2023 | 14 | 17 | $340.00 | $26.18 | 7.7% |
| J0690 | Injection, cefazolin sodium, 500 mg | Office | 2023 | 12 | 12 | $480.00 | $6.38 | 1.3% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2022 | 96 | 182 | $10,960 | $9,226 | 84.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 94 | 173 | $10,420 | $7,068 | 67.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 97 | 99 | $2,784 | $2,722 | 97.8% |
| 0094A | Adm sarscov2 50 mcg/.5 mlbst | Office | 2022 | 62 | 64 | $3,200 | $2,628 | 82.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 90 | 238 | $9,482 | $2,378 | 25.1% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 102 | 104 | $4,160 | $2,086 | 50.1% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 39 | 39 | $1,580 | $1,530 | 96.9% |
| 0013A | Adm sarscov2 100mcg/0.5ml3rd | Office | 2022 | 16 | 17 | $850.00 | $702.25 | 82.6% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 40 | 46 | $1,380 | $279.84 | 20.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 56 | 133 | $3,325 | $145.62 | 4.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 39 | 50 | $2,030 | $42.47 | 2.1% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 224 | 228 | $9,160 | $8,311 | 90.7% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 165 | 165 | $8,250 | $6,910 | 83.8% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2021 | 75 | 130 | $7,800 | $6,670 | 85.5% |
| 87811 | Sars-cov-2 covid19 w/optic | Office | 2021 | 75 | 118 | $7,080 | $4,883 | 69.0% |
About Dr. Leonel Apodaca, MD
Dr. Leonel Apodaca, MD is a Internal Medicine healthcare provider based in Coalinga, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699883157.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leonel Apodaca, MD has received a total of $1,513 in payments from pharmaceutical and medical device companies, with $145.80 received in 2024. These payments were reported across 77 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,513).
As a Medicare-enrolled provider, Apodaca has provided services to 3,121 Medicare beneficiaries, totaling 4,614 services with total Medicare billing of $100,114. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Coalinga, CA
- Active Since 08/26/2006
- Last Updated 08/21/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1699883157
Products in Payments
- JARDIANCE (Drug) $422.32
- STIOLTO RESPIMAT (Drug) $267.29
- OFEV (Drug) $116.71
- JANUVIA (Drug) $88.16
- Yupelri (Drug) $73.83
- BELSOMRA (Drug) $67.12
- GVOKE PFS (Drug) $66.86
- Ozempic (Drug) $59.07
- BREZTRI (Drug) $58.84
- XIFAXAN (Drug) $27.88
- PENNSAID (Drug) $19.50
- QBREXZA (Drug) $19.42
- SPIRIVA RESPIMAT (Drug) $18.92
- EVUSHELD (Drug) $18.87
- MOUNJARO (Drug) $18.57
- AIRSUPRA (Drug) $18.14
- FreeStyle Libre 2 (Device) $17.52
- TRULICITY (Drug) $16.54
- TZIELD (Biological) $16.08
- APTIMA (Device) $14.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.